Experienced in Hemiplegia

Dr. William B. Young

Physiatry
1103 N B St Ste D, 
Sacramento, CA 
Experienced in Hemiplegia
1103 N B St Ste D, 
Sacramento, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

William Young is a Physiatrist in Sacramento, California. Dr. Young is rated as an Experienced provider by MediFind in the treatment of Hemiplegia. His top areas of expertise are Alternating Hemiplegia of Childhood and Hemiplegia.

His clinical research consists of co-authoring 39 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Hemiplegia.

Specialties
Physiatry
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

1103 N B St Ste D, Sacramento, CA 95811

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2 Study of ABP-450 (prabotulinumtoxinA) Purified Neurotoxin Complex for the Prevention of Migraine Headache
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2 Study of ABP-450 (prabotulinumtoxinA) Purified Neurotoxin Complex for the Prevention of Migraine Headache
Enrollment Status: Completed
Publish Date: September 04, 2024
Intervention Type: Drug
Study Drug: ABP-450
Study Phase: Phase 2
An Open-Label, 12-Month Study to Evaluate the Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
An Open-Label, 12-Month Study to Evaluate the Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Drug: Dihydroergotamine
Study Phase: Phase 3
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: June 29, 2023
Intervention Type: Drug
Study Phase: Phase 3
Double-Blind, Placebo Controlled Trial of Greater Occipital Nerve Block for the Treatment of Migraine Attacks
Double-Blind, Placebo Controlled Trial of Greater Occipital Nerve Block for the Treatment of Migraine Attacks
Enrollment Status: Withdrawn
Publish Date: November 26, 2021
Intervention Type: Combination product, Drug
Study Phase: Phase 4
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
Enrollment Status: Unknown
Publish Date: June 26, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 4 Less Clinical Trials

39 Total Publications

Three years of remote electrical neuromodulation (REN) acute treatment for migraine shows consistent effectiveness and no tachyphylaxis phenomenon.
Three years of remote electrical neuromodulation (REN) acute treatment for migraine shows consistent effectiveness and no tachyphylaxis phenomenon.
Journal: Headache
Published: April 16, 2025
Similar Doctors
Advanced in Hemiplegia
Dr. Suleiman Lapalme
Physiatry
Advanced in Hemiplegia
Dr. Suleiman Lapalme
Physiatry

Kidney Transplant At Walnut Creek

1450 Treat Blvd, 
Walnut Creek, CA 
 (55.1 miles away)
925-296-9750
Languages Spoken:
English
See accepted insurances

Suleiman Lapalme is a Physiatrist in Walnut Creek, California. Dr. Lapalme is rated as an Advanced provider by MediFind in the treatment of Hemiplegia. His top areas of expertise are Stroke, Hemiplegia, Miller-Fisher Syndrome, and Guillain-Barre Syndrome.

Advanced in Hemiplegia
Dr. Jianxun Zhou
Physiatry
Advanced in Hemiplegia
Dr. Jianxun Zhou
Physiatry
1104 Corporate Way, 
Sacramento, CA 
 (6.8 miles away)
734-972-5824
Languages Spoken:
English
See accepted insurances

Jianxun Zhou is a Physiatrist in Sacramento, California. Dr. Zhou is rated as an Advanced provider by MediFind in the treatment of Hemiplegia. His top areas of expertise are Chronic Pain, Opioid Induced Constipation, Muscle Spasms, and Opisthotonos.

Advanced in Hemiplegia
Dr. John A. Dana
Physiatry
Advanced in Hemiplegia
Dr. John A. Dana
Physiatry

John Muir Physician Network

1450 Treat Blvd, Suite 200, 
Walnut Creek, CA 
 (55.1 miles away)
925-296-9860
Languages Spoken:
English, Korean, Spanish
See accepted insurances

John Dana is a Physiatrist in Walnut Creek, California. Dr. Dana is rated as an Advanced provider by MediFind in the treatment of Hemiplegia. His top areas of expertise are Stroke, Subdural Hematoma, Chronic Subdural Hematoma, and Hemiplegia.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Young's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile